Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting
Validation of the Accuracy of a Novel POCT Dry Electrolyte Analysis System in the Acute Care Setting: A Cross-Sectional Study
Zhujiang Hospital
200 participants
Dec 17, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this study is to compare the performance of a novel Point-of-Care Testing (POCT) dry electrolyte analyzer (P1) with the Nova Stat Profile pHOx Ultra Analyzer System (Nova) in an acute care setting. The main questions it aims to answer are: 1. How consistent are the results between P1 and Nova in the emergency setting, including outliers, correlation, linearity, and bias? 2. Whether P1 can serve as a suitable alternative to Nova in the acute care setting for electrolyte measurement in the emergency environment. Participants will be patients in the emergency department who will undergo simultaneous measurement with P1 and Nova during their emergency care to assess the performance of both devices. Additionally, the study will investigate electrolyte levels in emergency patients, focusing on the prevalence of abnormal ionized magnesium (iMg2+) levels, the correlation between iMg2+ and total magnesium (tMg), and the clinical significance of iMg2+ measurement.
Eligibility
Inclusion Criteria1
- Patients who are scheduled to undergo electrolyte measuring in the emergency department (ED) or emergency intensive care unit (ICU).
Exclusion Criteria4
- Patients with a confirmed history of infectious diseases such as hepatitis B, syphilis, HIV/AIDS, etc.
- Missing residual sample types (serum or whole blood).
- Patients whose residual blood samples are not tested within the specified time frame after collection.
- Other patients deemed ineligible by the investigator.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
This group involves the use of Nova for measuring serum and whole blood samples. The results from Nova will be compared with those obtained from P1.
This group involves the use of P1 for measuring serum and whole blood samples. The results from P1 will be compared with those obtained from Nova.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06726460